PubMed ID: 38827491 Author(s): Domalpally A, Slater R, Linderman RE, Balaji R, Bogost J, Voland R, Pak J, Blodi BA, Channa R, Fong D, Chew EY. Strong versus Weak Data Labeling for Artificial Intelligence Algorithms …
Barbara Blodi
Strong versus Weak Data Labeling for Artificial Intelligence Algorithms in the Measurement of Geographic Atrophy.
PubMed ID: 38827491 Author(s): Domalpally A, Slater R, Linderman RE, Balaji R, Bogost J, Voland R, Pak J, Blodi BA, Channa R, Fong D, Chew EY. Strong versus Weak Data Labeling for Artificial Intelligence Algorithms …
Strong versus Weak Data Labeling for Artificial Intelligence Algorithms in the Measurement of Geographic Atrophy.
PubMed ID: 38827491 Author(s): Domalpally A, Slater R, Linderman RE, Balaji R, Bogost J, Voland R, Pak J, Blodi BA, Channa R, Fong D, Chew EY. Strong versus Weak Data Labeling for Artificial Intelligence Algorithms …
Reply.
PubMed ID: 38573249 Author(s): Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA. Reply. Ophthalmology. 2024 Jun;131(6):e25-e26. doi: 10.1016/j.ophtha.2024.02.016. Epub 2024 Apr 1. No abstract available. PMID 38573249 Journal: Ophthalmology, Volume 131, Issue 6, …
Association of Retinal Thickness at Month 1 Postrandomization With Later Thickness and Visual Acuity in Central Vein Occlusion.
PubMed ID: 38705553 Author(s): Scott IU, Oden NL, Ip MS, VanVeldhuisen PC, Blodi BA; SCORE2 Study Investigator Group. Association of Retinal Thickness at Month 1 Postrandomization With Later Thickness and Visual Acuity in Central Vein …
Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein Occlusion.
PubMed ID: 38061584 Author(s): Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA; SCORE2 Investigator Group. Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central …
Thrombospondin-1, BIM and CFH polymorphisms and response to anti-VEGF treatment in neovascular age- related macular degeneration patients.
PubMed ID: 38408093 Author(s): Sorenson CM, Gurel Z, Song YS, Peterson KD, Blodi BA, Sheibani N. Thrombospondin-1, BIM and CFH polymorphisms and response to anti-VEGF treatment in neovascular age- related macular degeneration patients. PLoS One. …
Month 60 Imaging Findings and Relationship to Treatment Outcomes following Anti-VEGF Therapy for Macular Edema due to Central or Hemi Retinal Vein Occlusion.
PubMed ID: 38061584 Author(s): Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA; SCORE2 Investigator Group. Month 60 Imaging Findings and Relationship to Treatment Outcomes following Anti-VEGF Therapy for Macular Edema due to Central …
Intraocular Pressure in Eyes With Retinal Vein Occlusion Compared With Fellow Eyes: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 27.
PubMed ID: 37943541 Author(s): Aref AA, Scott IU, Oden NL, Ip MS, VanVeldhuisen PC, Blodi BA; SCORE and SCORE2 Study Investigator Groups. Intraocular Pressure in Eyes With Retinal Vein Occlusion Compared With Fellow Eyes: Study …